Your browser doesn't support javascript.
loading
Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
Wohl, David A; Yazdanpanah, Yazdan; Baumgarten, Axel; Clarke, Amanda; Thompson, Melanie A; Brinson, Cynthia; Hagins, Debbie; Ramgopal, Moti N; Antinori, Andrea; Wei, Xuelian; Acosta, Rima; Collins, Sean E; Brainard, Diana; Martin, Hal.
Afiliação
  • Wohl DA; Department of Medicine, Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Yazdanpanah Y; Department of Medicine, Paris Diderot University, Paris, France.
  • Baumgarten A; Zentrum für Infektiologie Berlin Prenzlauer Berg, Berlin, Germany.
  • Clarke A; Claude Nicol Centre, Royal Sussex County Hospital, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.
  • Thompson MA; AIDS Research Consortium of Atlanta, Atlanta, GA, USA.
  • Brinson C; Central Texas Clinical Research, Austin, TX, USA.
  • Hagins D; Georgia Department of Public Health, Coastal Health District, Chatham Care Center, Savannah, GA, USA.
  • Ramgopal MN; Midway Immunology Center, Fort Pierce, FL, USA.
  • Antinori A; National Institute for Infectious Diseases Lazzaro Spallanzani-IRCCS, Roma, Italy.
  • Wei X; Department of Biometrics, Gilead Sciences Inc, Foster City, CA, USA.
  • Acosta R; Department of Virology, Gilead Sciences Inc, Foster City, CA, USA.
  • Collins SE; Department of HIV Clinical Research, Gilead Sciences Inc, Foster City, CA, USA. Electronic address: sean.collins@gilead.com.
  • Brainard D; Department of HIV Clinical Research, Gilead Sciences Inc, Foster City, CA, USA.
  • Martin H; Department of HIV Clinical Research, Gilead Sciences Inc, Foster City, CA, USA.
Lancet HIV ; 6(6): e355-e363, 2019 06.
Article em En | MEDLINE | ID: mdl-31068270

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Terapia Antirretroviral de Alta Atividade Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Lancet HIV Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Infecções por HIV / HIV-1 / Fármacos Anti-HIV / Terapia Antirretroviral de Alta Atividade Tipo de estudo: Clinical_trials Limite: Female / Humans / Male Idioma: En Revista: Lancet HIV Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos